14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RLYB
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very red day for Rallybio Corporation stock price after a -6.15% fall in the Monday trading session
(Updated on Jun 17, 2024)

Sell candidate since May 31, 2024 Loss -13.17% PDF

The Rallybio Corporation stock price fell by -6.15% on the last day (Monday, 17th Jun 2024) from $1.55 to $1.45. During the last trading day the stock fluctuated 8.68% from a day low at $1.44 to a day high of $1.57. The price has been going up and down for this period, and there has been a -6.45% loss for the last 2 weeks. Volume has increased on the last day by 66 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 198 thousand shares were bought and sold for approximately $286.60 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.34 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -4.84% during the next 3 months and, with a 90% probability hold a price between $1.27 and $2.73 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RLYB Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Rallybio Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.56 and $1.70. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 11, 2024, and so far it has fallen -51.34%. Further fall is indicated until a new bottom pivot has been found. Rallybio Corporation gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Rallybio Corporation stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.125 between high and low, or 8.68%. For the last week, the stock has had daily average volatility of 8.65%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RLYB) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Rallybio Corporation to open at $1.49, and during the day (based on 14 day Average True Range), to move between $1.32 and $1.58, which gives a possible trading interval of +/-$0.133 (+/-9.16%) up or down from last closing price. If Rallybio Corporation takes out the full calculated possible swing range there will be an estimated 18.33% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.59, some $0.140 (9.66%) from the current price of $1.45, our system finds the risk reward not very attractive.

Is Rallybio Corporation stock A Buy?

Rallybio Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.241 Sell Candidate Unchanged

Predicted Opening Price for Rallybio Corporation of Tuesday, June 18, 2024

Fair opening price June 18, 2024 Current price
$1.49 ( 2.41%) $1.45

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RLYB

Fibonacci Support & Resistance Levels

Level Price
R3 1.61 11.03%
R2 1.56 7.74%
R1 1.53 5.71%
Price 1.45
S1 1.44 -0.88%
S2 1.41 -2.91%
S3 1.36 -6.21%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.80 24.14%
R2 1.76 21.38%
R1 1.59 9.66%
Price 1.45
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Rallybio Corporation Stock and on which exchange is it traded?
The symbol for Rallybio Corporation is RLYB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rallybio Corporation Stock?
Rallybio Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Rallybio Corporation Stock?
Rallybio Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rallybio Corporation Stock.

What's the current price of Rallybio Corporation Stock?
As of the end of day on the Jun 17, 2024, the price of an Rallybio Corporation (RLYB) share was $1.45.

What is the 52-week high and low for Rallybio Corporation Stock?
The 52-week high for Rallybio Corporation Stock is $8.20 and the 52-week low is $1.23.

What is the market capitalization of Rallybio Corporation Stock?
As of the Jun 17, 2024, the market capitalization of Rallybio Corporation is 60.101M.

When is the next earnings date for Rallybio Corporation?
The upcoming earnings date for Rallybio Corporation is Aug 13, 2024.
Click to get the best stock tips daily for free!

About Rallybio Corporation

Rallybio Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclona... RLYB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT